doc. MUDr. Alexandr Poprach, Ph.D.
Associate professor, Comprehensive Cancer Care Department
Total number of publications: 151
2025
-
Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study
EUROPEAN UROLOGY ONCOLOGY, year: 2025, volume: 8, edition: 2, DOI
-
Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial
Lancet Oncology, year: 2025, volume: 26, edition: 4, DOI
-
Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, year: 2025, volume: 17, edition: May 2025, DOI
-
ProstaPilot: A Comparative Study of Biparametric Magnetic Resonance Imaging Versus Prostate-specific Antigen as a Screening Test for Prostate Cancer
EUROPEAN UROLOGY OPEN SCIENCE, year: 2025, volume: 76, edition: June 2025, DOI
2024
-
11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET)
BMC Cancer, year: 2024, volume: 24, edition: 1, DOI
-
Aktuální klinické charakteristiky a léčebné postupy karcinomu plic v onkologickém centru v České republice z reálné praxe - data z registru Masarykova onkologického ústavu z let 2018-2022
Klinická onkologie, year: 2024, volume: 39, edition: 6, DOI
-
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
New England Journal of Medicine, year: 2024, volume: 391, edition: 8, DOI
-
Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic - data from Masaryk Memorial Cancer Institute registry in 2018-2022
Klinická onkologie, year: 2024, volume: 37, edition: 6, DOI
-
Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer
BMC Cancer, year: 2024, volume: 24, edition: 1, DOI
-
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study
Targeted Oncology, year: 2024, volume: 19, edition: 6, DOI